tiprankstipranks
Minerva Surgical (UTRS)
OTHER OTC:UTRS
US Market
Holding UTRS?
Track your performance easily

Minerva Surgical (UTRS) Income Statement

63 Followers

Minerva Surgical Income Statement

Last quarter (Q2 2023), Minerva Surgical's total revenue was $13.39M, an increase of 3.27% from the same quarter last year. In Q2, Minerva Surgical's net income was $-8.68M. See Minerva Surgical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 52.32M$ 50.29M$ 52.10M$ 37.77M$ 26.01M
Cost of Revenue
$ 23.71M$ -23.05M$ 21.58M$ 18.65M$ 14.21M
Gross Profit
$ 28.60M$ 27.24M$ 30.52M$ 19.12M$ 11.80M
Operating Expense
$ 62.31M$ -58.14M$ 60.01M$ 34.51M$ 31.44M
Operating Income
$ -33.71M$ -30.97M$ -29.48M$ -15.39M$ -19.64M
Net Non Operating Interest Income Expense
$ -3.84M$ -3.13M$ -11.72M$ -12.06M$ -17.44M
Other Income Expense
$ -126.00K$ -100.00K$ -19.75M$ 9.05M$ -14.96M
Pretax Income
$ -37.55M$ -34.10M$ -21.45M$ -18.39M$ -52.05M
Tax Provision
$ 50.00K$ 11.00K$ 9.00K$ -132.00K$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -37.60M$ -34.11M$ -21.46M$ -18.26M$ -52.05M
Basic EPS
$ -1.15$ -1.18$ -3.06$ -1.09$ -2.81
Diluted EPS
$ -0.77$ -1.18$ -3.06$ -1.09$ -2.81
Basic Average Shares
$ 296.76M$ 28.91M$ 7.01M$ 18.54M$ 18.54M
Diluted Average Shares
$ 296.76M$ 28.91M$ 7.01M$ 18.54M$ 18.54M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 86.02M$ -81.19M$ 81.59M$ 53.16M$ 45.65M
Net Income From Continuing And Discontinued Operation
$ -37.60M$ -34.11M$ -21.46M$ -18.26M$ -52.05M
Normalized Income
$ -11.33M--$ -27.18M$ -36.91M
Interest Expense
$ 861.00K--$ 12.14M$ 17.58M
EBIT
$ -33.48M$ -30.88M$ -9.73M$ -6.25M$ -34.47M
EBITDA
$ -22.51M$ -19.82M$ -9.73M$ 821.00K$ -32.79M
Currency in USD

Minerva Surgical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis